• Users Online: 510
  • Print this page
  • Email this page
Year : 2017  |  Volume : 1  |  Issue : 6  |  Page : 28-30

The bacteremia antibiotic length actually needed for clinical effectiveness research program (balance.ccctg.ca)

Sunnybrook Hospital, the University of Toronto, Toronto, Ontario, Canada

Correspondence Address:
Robert Fowler
MDCM, MS (Epi), FRCP(C), 2075 Bayview Avenue, Room D478, Sunnybrook Hospital, Toronto, Ontario
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2543-1854.219135

Rights and Permissions

A multitude of global health organizations have declared antimicrobial resistance a threat to health, based on rapidly increasing resistance rates and declining new drug development. Up to 30%–50% of antibiotic use is estimated to be inappropriate, and excessive durations of treatment are the greatest contributor to inappropriate use. A landmark trial in critically ill patients with ventilator-associated pneumonia showed that mortality and relapse rates were noninferior in patients who received 8 versus 15 days of treatment, but similar evidence is lacking for the treatment of patients with bloodstream infection, which affects 15% of critically ill patients. The Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) research program was initiated to provide evidence-based guidance on this question.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded197    
    Comments [Add]    

Recommend this journal